Flexion Therapeutics (FLXN) PT Lowered to $17 at Benchmark

April 2, 2020 7:39 AM EDT Send to a Friend

Benchmark analyst Bruce Jackson lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Flexion Therapeutics (FLXN) PT Lowered to $17 at Benchmark

Member Login

Free News Feed